1Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density.Cell,1997,89:309-319.
2Tsuda E,Goto M,Mochizuki S,et al.Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.Biochem Biophys Res Commun,1997,234:137-142.
3MorinagaT,Nakagawa N,Yasuda H,et al.Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor.Eur J Biochem,1998,254:685-691.
4Jorgensen HL,Kusk P,Madsen B,et al.Serum osteoprotegerin (OPG) and the A 163 G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.J Bone Miner Metab,2004,22:132-138.
5Langdahl BL,Carstens M,Stenkjaer L,et al.Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.J Bone Miner Res,2002,17:1245-1255.
6Cboi JY,Shin A,Park SK,et al.Genetic polymorphisms of OPG,RANK,and ESR1 and bone mineral density in Korean postmenopausal women.Calcif Tissue Int,2005,77:152-159.Epub 2005,Sep 8.
7Arko B,Prezelj J,Komel R,et al.Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.J Clin Endocrinol Metab,2002,87:4080-4084.
8Yamada Y,Ando F,Niino N,et al.Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.Mol Genet Metab,2003,80:344-349.
10Wynne F,Drummond F,O'Sullivan K,et al.Investigation of the genetic influence of the OPG,VDR (Fokl),and COLIA1 Sp1 polymorphisms on BMD in the Irish population.Calcif Tissue Int,2002,71:26-35.
二级参考文献52
1[1]Eisman JA. Genetics of osteoporosis [J]. Endocr Rev,1999, 20(6):788-804.
2[2]Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell,1997,89(2):309-319.
3[3]Bucay N, Sarosi I, Dunstan CR, et al.osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[J].Genes Dev, 1998,12(9): 1260-1268.
4[4]Mizuno A, Amizuka N, Irie K, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin [J]. Biochem Biophys Res Commun, 1998,247(3):610-615.
5[5]Langdahl BL, Carstens M, Stenkjaer L, et al. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures[J]. J Bone Miner Res, 2002,17(7):1245-1255.
6[6]Arko B, Prezelj J, Komel R, et al. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis [J]. J Clin Endocrinol Metab,2002, 87(9):4080-4084.
7[8]Alderborn A, Kristofferson A, Hammering U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing [J]. Genome Res,2000,10(8): 1249-1258.
8[9]Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis [J]. J Bone Miner Res, 1994,9(8):1137-1141.
9[10]Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis[J]. Endocr Rev,2000,21(2):115-137.
10[11]Tsuda E, Goto M, Mochizuki S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis [J].Biochem Biophys Res Commun,1997,234(1): 137-142.
